SCHEMBL5566630

SCHEMBL5566630

CCC(F)(C(=O)O)C(=O)C(F)F

nearest known ligand 0.35

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
CES2 O00748 1/20 0.30
LPAR1 Q92633 2/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19607726 0.80 FFAR3 (0.37) CES2
SCHEMBL10452071 0.79 CES2 (0.38) CES2LPAR1
SCHEMBL29186815 0.78 FFAR3 (0.35) CES2
SCHEMBL2414698 0.73 ALDH1A1 (0.32)
SCHEMBL10457329 0.72 ALDH1A1 (0.35)
SCHEMBL6902951 0.71 CES2 (0.39) CES2
SCHEMBL4384467 0.70 FAAH (0.32) CES2
SCHEMBL1787333 0.69 ALDH1A1 (0.36)
Lithium Ion SCHEMBL25327835 0.68
SCHEMBL22208158 0.67 ALDH1A1 (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11434371-B2 Room temperature storage-stable UV/VIS and moisture dual curable polysiloxane composition DOW SILICONES CORPORATION (US) 2022-09-06 US claimed
US-20210139703-A1 ROOM TEMPERATURE STORAGE-STABLE UV/VIS AND MOISTURE DUAL CURABLE POLYSILOXANE COMPOSITION DOW SILICONES CORPORATION 2021-05-13 US claimed
US-4883904-A Process for the preparation of ethyltrifluoroacetoacetate RHONE-POULENC SPECIALITES CHIMIQUES (FR) 1989-11-28 US claimed
EP-0206953-B1 PROCESS FOR THE PREPARATION OF ETHYL TRIFLUOROACETOACETATE RHONE-POULENC CHIMIE (FR) 1988-09-07 EP claimed
US-12577409-B2 Powder coating composition ALLNEX NETHERLANDS B.V. (NL) 2026-03-17 US disclosed
US-20250129031-A1 1,2,3-TRIAZOLE CARBONYL SULFONYLAMIDE COMPOUNDS AND USE THEREOF PI INDUSTRIES LTD (IN) 2025-04-24 US disclosed
EP-4469442-A1 1,2,3-TRIAZOLE CARBONYL SULFONYLAMIDE COMPOUNDS AND USE THEREOF PI Industries Ltd. (IN) 2024-12-04 EP disclosed
US-20240166884-A1 POWDER COATING COMPOSITION ALLNEX NETHERLANDS B.V. (NL) 2024-05-23 US disclosed
US-11920058-B2 Powder coating composition ALLNEX NETHERLANDS B.V. (NL) 2024-03-05 US disclosed
WO-2023144711-A1 1,2,3-TRIAZOLE CARBONYL SULFONYLAMIDE COMPOUNDS AND USE THEREOF PI INDUSTRIES LTD. (IN) 2023-08-03 WO disclosed
CN-116018341-A Herbicidal compounds 先正达农作物保护股份公司 2023-04-25 CN disclosed
CN-115884966-A Bicyclic compounds and uses thereof 贝达药业股份有限公司 2023-03-31 CN disclosed
US-20010034379-A1 Process for curing a polymerizable composition VALET ANDREAS (DE) 2001-10-25 US disclosed
EP-0909288-A1 PROCESS FOR CURING A POLYMERIZABLE COMPOSITION Ciba SC Holding AG (CH) 1999-04-21 EP disclosed
EP-0694526-B1 Process for preparation of fluorinated beta-keto ester ROHM & HAAS (US) 1998-10-07 EP disclosed
WO-1998000456-A1 PROCESS FOR CURING A POLYMERIZABLE COMPOSITION CIBA SPECIALITY CHEMICALS HOLDING INC. (CH) 1998-01-08 WO disclosed
US-4883904-A Process for the preparation of ethyltrifluoroacetoacetate RHONE-POULENC SPECIALITES CHIMIQUES (FR) 1989-11-28 US disclosed
US-4883904-A Process for the preparation of ethyltrifluoroacetoacetate RHONE-POULENC SPECIALITES CHIMIQUES (FR) 1989-11-28 US disclosed
US-4883904-A Process for the preparation of ethyltrifluoroacetoacetate RHONE-POULENC SPECIALITES CHIMIQUES (FR) 1989-11-28 US disclosed
US-4590096-A USING ORGANOTIN COMPOUND AND ORGANIC FLUORINE DOPANT-CONTROLLING HUMIDITY OF CARRIER GAS STREAM M&T CHEMICALS INC. (US) 1986-05-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250129031-A1 1,2,3-TRIAZOLE CARBONYL SULFONYLAMIDE COMPOUNDS AND USE THEREOF GLP1R, CBR3, CBR1 CES2 232/4885LPAR1 3805/4885
US-12577409-B2 Powder coating composition MCCC2, MLEC, MAP1LC3C CES2 2804/4885LPAR1 3220/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.